This Report offers a comprehensive review of the global protease market. The Report discusses strategies to design peptidomimetic and non-peptidomimetic competitive inhibitors, as well as other types of inhibitors. The main disease areas where proteases or their inhibitors are involved include infectious diseases, inflammation and wounds, cancer, cardiovascular conditions, neurodegenerative diseases, and more are examined. In addition, this report profiles key companies active in the protease drug discovery area.
